Genprex, Inc.
A clinical-stage firm developing non-viral gene therapies for cancer and diabetes.
GNPX | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 1601 TRINITY STREET, BLDG. B, 78712 AUSTIN
- Website:
- https://www.genprex.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company's therapeutic approach involves its proprietary Oncoprex® immunogene therapy platform, a non-viral delivery system designed to administer disease-fighting genes. Its lead drug candidate, Reqorsa® (tarsagene tolimulovec), focuses on reintroducing tumor suppressor genes to combat cancer and has received multiple FDA Fast Track Designations. Genprex is also developing GPX-002, a gene therapy candidate for treating diabetes. The company aims to provide new therapeutic options for large patient populations with significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Genprex, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Genprex, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Genprex, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
